From the country’s strategy for tackling COVID-19 to U.S.-China tensions to government regulations, some key changes can be expected under the coming Biden administration. At…
An intranasal vaccine, an mRNA vaccine, and a T-cell activation vaccine: the three biotech companies discussed in today’s article are approaching the virus that causes…
“Call it what you will, but I think traders who’ve dug into the biotech space initially came for the COVID, then figured out there’s far…
“Amid a relatively dry IPO year, biotech IPOs have boomed,” notes the author of today’s article, who proceeds to highlight what he believes are two…
Shares of the biotech highlighted in today’s article have soared this year, but is this performance due to factors such as the COVID-19 drug the…
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
When it comes to biotech stocks, the author of today’s article advises that “While you can get access to many of these firms via exchange-traded…
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…
“The search for a Covid-19 cure and an end to global shutdowns has created a new type of investor in health-care stocks: the biotech tourist,”…
“With the scramble for viral and antibody testing kits, and the ultimate goal of finding a vaccine for Covid-19, many biotech companies are suddenly in…